Table 1.
Basic Situation of Participants in the Study.
| T2DM (n=6) | Prediabetes (n=6) | Control (n=6) | χ2/F | P | |
|---|---|---|---|---|---|
| Gender (male/female) | 4/2 | 4/2 | 2/4 | 1.761 | 0.589 |
| Age (year) | 54 ± 6.03 | 53.17 ± 3.13 | 52 ± 6.26 | 0.213 | 0.811 |
| Weight (kg) | 65 (61.25, 75) | 65 (62.25, 66.25) | 60 (58.75, 77.5) | 0.693 | 0.707 |
| Height (cm) | 170.33 ± 5.16 | 168.67 ± 6.98 | 164.83 ± 6.80 | 1.178 | 0.335 |
| BMI (kg/m2) | 22.62 ± 2.49 | 22.84 ± 2.39 | 24.1 ± 2.7 | 0.594 | 0.565 |
| TC (mmol/L) | 4.86 ± 0.92 | 5.19 ± 0.63 | 5.94 ± 1.2 | 2.072 | 0.160 |
| LDL (mmol/L) | 2.65 ± 0.52 | 2.92 ± 0.47 | 3.52 ± 0.56 | 4.496 | 0.030 |
| HDL (mmol/L) | 1.09 (0.85, 1.23) | 1.04 (0.86, 1.35) | 1.31 (1.1, 2.11) | 4.060 | 0.131 |
| TG (mmo/L) | 2.59 (2.24, 6.51) | 2.5 (1.98, 7.59) | 2.29 (1.98, 3.24) | 0.947 | 0.623 |
| Lipoprotein (a) (mg/L) | 30.5 (13.5, 213.5) | 121 (24.25, 267.5) | 66 (36.5, 340.75) | 1.263 | 0.532 |
| Creatinine (μmoI/L) | 63.2 ± 7.26 | 106.5 ± 7.78 | 68 ± 13.29 | 13.103 | 0.002 |
| Uric acid (μmoI/L) | 352.5 ± 40 | 389 ± 65.05 | 399 ± 116.84 | 0.314 | 0.739 |
| ALT (U/L) | 18.75 ± 0.96 | 22.25 ± 5.74 | 19 ± 4.08 | 0.906 | 0.438 |
| AST (U/L) | 22 (19, 24.25) | 19.5 (12.25, 35) | 23 (16.25, 24.5) | 0.554 | 0.758 |
| FPG (mmol/L) | 8.8 (7.95, 13.15) | 6.55 (6.28, 6.65) | 5.25 (4.88, 5.5) | 15.205 | <0.001 |
| A1C (mmol/mol) | 85.8 ± 17.43 | 46.67 ± 1.53 | 38.5 ± 2.12 | 13.081 | 0.004 |
| A1C (%) | 9.96 ± 1.58 | 6.47 ± 0.15 | 5.7 ± 0.14 | 12.832 | 0.005 |